Hepatitis C Virus NS5A Inhibitor

DBCAT003507Therapeutic category

A DrugBank category of 6 drugs. 6 of them are approved.

What you can answer from here — as of March 15, 2022

6DrugsEach linked to its full drug card
Listed above
3Drug targetsEvery drug–target pair in the class, with bond type
Sign in
107Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
1Route of administrationHow the drugs in this class are given
Sign in

Which targets do Hepatitis C Virus NS5A Inhibitor share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.

Create Account